Back to Journals » Drug Design, Development and Therapy » Volume 12

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Total article views   Abstract views HTML views PDF downloads Totals
8,842 Dovepress* 7,206 961+ 724 8,167
PubMed Central* 0 675 173 675
Totals 7,206 1,636 897 8,842
*Since 19 December 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar